SpectraWAVE Secures $50M in Series B to Advance HyperVue™ Imaging System for Coronary Artery Disease Treatment
Slice of Healthcare Team
09/13/2024
Key Highlights
- SpectraWAVE raises $50M in Series B led by Johnson & Johnson Innovation - JJDC, Inc.
- HyperVue™ Imaging System integrates DeepOCT and NIRS to improve coronary stenting procedures.
- Funding supports commercial expansion and product development, enhancing care for CAD patients.
- Backed by leading MedTech investors including S3 Ventures, Lumira Ventures, and more.
Source: Business Wire
Notable Quote
“ Intravascular imaging guidance is backed by a wealth of randomized clinical trials (RCT) and recently collated in a meta-analysis of 22 RCT studies and approximately 16,000 patients published this year in The Lancet, demonstrating significantly improved outcomes for patients undergoing coronary stenting. This financing, supported by leading MedTech investors, will support our commercial expansion to bring HyperVue to more patients. ”
Eman Namati, Ph.D., Chief Executive Officer at SpectraWAVE
